Alzheimer's disease biomarkers detection in human samples by efficient capturing through porous magnetic microspheres and labelling with electrocatalytic gold nanoparticles

Biosensors and Bioelectronics

Volumn 67, Issue , 2015, Pages 162-169

  de la Escosura Muñiz, Alfredo ^a   Plichta, Zdeněk ^b   Horák, Daniel ^b   Merkoçi, Arben ^a,c  

^a CATALAN INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY ICN2   (Spain)

^b INSTITUTE OF MACROMOLECULAR CHEMISTRY   (Czech Republic)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

Alzheimer disease biomarker; Electrochemical immunoassay; Gold nanoparticles; Hydrogen evolution reaction; Porous magnetic microspheres

Indexed keywords

BIOMARKERS; BODY FLUIDS; CATALYST ACTIVITY; CEREBROSPINAL FLUID; FIBER OPTIC SENSORS; FUNCTIONAL GROUPS; GOLD; HYDROGEN; METAL NANOPARTICLES; MICROSPHERES; NANOPARTICLES; NEURODEGENERATIVE DISEASES; PRECIPITATION (CHEMICAL); TRANSMISSION ELECTRON MICROSCOPY;

ALZHEIMER DISEASE; ELECTROCHEMICAL IMMUNOASSAYS; GOLD NANOPARTICLES; HYDROGEN EVOLUTION REACTIONS; MAGNETIC MICROSPHERES;

NANOMAGNETICS;

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; CARBONYL DERIVATIVE; GOLD NANOPARTICLE; IRON OXIDE; MICROSPHERE; POROUS MAGNETIC MICROSPHERE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; GOLD; METAL NANOPARTICLE;

ALZHEIMER DISEASE; ARTICLE; BLOOD SAMPLING; CATALYSIS; CHEMICAL LABELING; CONTROLLED STUDY; DARK FIELD MICROSCOPE; ELECTROCATALYSIS; ELECTROCHEMICAL DETECTION; HUMAN; HYDROGEN EVOLUTION; INTERMETHOD COMPARISON; MICROTECHNOLOGY; NANOFABRICATION; NANOSENSOR; POLYMERIZATION; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; SCANNING TRANSMISSION ELECTRON MICROSCOPY; CHEMISTRY; CONDUCTOMETRY; IMMUNOMAGNETIC SEPARATION; METABOLISM; POROSITY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STAINING; ULTRASTRUCTURE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; APOLIPOPROTEINS E; BIOMARKERS; CATALYSIS; CONDUCTOMETRY; GOLD; HUMANS; IMMUNOMAGNETIC SEPARATION; METAL NANOPARTICLES; MICROSPHERES; POROSITY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STAINING AND LABELING;

EID: 84922276307     PISSN: 09565663     EISSN: 18734235     Source Type: Journal    
DOI: 10.1016/j.bios.2014.07.086     Document Type: Article

References (30)

1. Ambrosi A., Castañeda M.T., Killard A.J., Smith M.R., Alegret S., Merkoçi A. Anal. Chem. 2007, 79:5232-5240.
2. De la Escosura-Muñiz A., Sánchez-Espinel C., Díaz-Feitas B., González-Fernández A., Maltez-da Costa M., Merkoçi A. Anal. Chem. 2009, 81:10268-10274.
3. De la Escosura-Muñiz A., Merkoçi A. Expert Opin. Med. Diagn. 2010, 4(1):21-37.
4. De la Escosura-Muñiz A., Maltez-da Costa A., Sánchez Espinel C., Díaz-Freitas B., Fernández-Suárez J., González-Fernández A., Merkoçi A. Biosens. Bioelectron. 2010, 26:1710-1714.
5. De Meyer G., Shapiro F., Vanderstichele H., Vanmechelen E., Engelborghs S., De Deyn P.P., Coart E., Hansson O., Minthon L., Zetterberg H., Blennow K., Shaw L., Trojanowski J.Q. Arch. Neurol. 2010, 67:949-956.
6. Dreaden E.C., Alkilany A.M., Huang X., Murphy C.J., El-Sayed M.A. Chem. Soc. Rev. 2012, 41:2740-2749.
7. Bateman R.J., Munsell L.Y., Morris J.C., Swarm R., Yarasheski K.E., Holtzman D.M. Nat. Med. 2006, 12:856-861.
8. Brookmeyer R., Johnson E., Ziegler-Graham K., Arrighi M.H. Alzheimer''s Dementia 2007, 3:186-191.
9. Gustafson D.R., Skoog I., Rosengren L., Zetterberg H., Blennow K. Neurol. Neurosurg. Psychiatry 2007, 78(5):461-464.
10. Hardy J., Allsop D. Trends Pharmacol. Sci. 1991, 12:383-388.
11. Horák D., Kucerova J., Korecka L., Jankovicova B., Palarci k J., Mikulasek P., Bi lkova S. Macromol. Biosci. 2012, 12:647-655.
12. Horák D., Svobodová Z., Autebert J., Coudert B., Královec K., Plichta Z., Bílková Z., Viovy J.L. J. Biomed. Mater. Res.: Part A 2013, 101A:23-32.
13. Lee P.H., Bang O.Y., Hwang E.M., Lee J.S., Joo U.S., Mook-Jung I., Huh K. J. Neural Transm. 2005, 112:1371-1379.
14. Maltez-da Costa M., De la Escosura-Muñiz A., Merkoçi A. Electrochem. Commun. 2010, 12:1501-1504.
15. Merkoçi A. Biosens. Bioelectron. 2010, 26:1164-1177.
16. Marksteiner J., Hinterhuber H., Humpel C. Drugs Today 2007, 43:423-431.
17. Medina-Sánchez M., Miserere S., Morales-Narváez E., Merkoçi A. Biosens. Bioelectron. 2014, 54:279-284.
18. Morales-Narváez E., Montón H., Fomicheva A., Merkoçi A. Anal. Chem. 2012, 2012(84):6821-6827.
19. Palop J.J., Mucke L. Nat. Neurosci. 2010, 13:812-818.
20. Parolo C., De la Escosura-Muñiz A., Polo E., Grazú V., de la Fuente J.M., Merkoçi A. ACS Appl. Mater. Interfaces 2013, 5:10753--10759.
21. Polvikoski T. N. Engl. J. Med. 1995, 333:1242-1247.
22. Shiga K., Muramatsu N., Kondo T. J. Pharm. Pharmacol. 1996, 48:891-895.
23. Smigol V., Svec F. J. Appl. Polym. Sci. 1992, 46:1439-1448.
24. Taddeia K., Clarnette R., Gandy S.E., Martins R.N. Neurosci. Lett. 1997, 223:29-32.
25. Turkevich J., Stevenson P., Hillier J. Discuss. Faraday Soc. 1951, 11:55-75.
26. Ugelstad, J., Ellingsen, T., Berge, A., Helgee, B. 1983. Eur. Patent WO 83/03920.
27. Vincent-Viry M., Schiele F., Gueguen R., Bohnet K., Visvikis S. Clin. Chem. 1998, 44:957-965.
28. Wichterle O. Encyclopedia of Polymer Science and Technology, vol. 15 1971, John Wiley & Sons, New York. H.F. Mark, N.G. Gaylord, N.M. Bikales (Eds.).
29. Zhang D.H., Zhang Y.F., Zhi G.Y., Xie Y.L. Colloids Surf. B 2011, 82:302-306.
30. Wahrle S.E., Shah A.R., Fagan A.M., Smemo S., Kauwe J.S.K., Grupe A., Hinrichs A., Mayo K., Jiang H., Thal L.J., Goate A.M., Holtzman D.M. Mol. Neurodegener. 2007, 2:7.